Product Benefits:

• Helps reduce symptoms of rheumatoid arthritis (RA) and improve physical function in patients with inadequate response or intolerance to methotrexate.

• Effective for psoriatic arthritis in adults who have had an inadequate response to other DMARDs. 

• Also indicated for moderately to severely active ulcerative colitis in adults, helping achieve clinical remission. 

• Oral tablet formulation allows for convenient daily administration. 

• Manufactured locally by Incepta Pharmaceuticals Ltd. for accessibility in the Bangladesh market